Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 2, 2012

Ingenuity, Life Tech Introduce Solution for Real-Time PCR Gene-Expression Analysis

  • Ingenuity Systems and Life Technologies are launching the Ingenuity iReport for real-time PCR optimized for TaqMan® gene-expression assays including TaqMan Array Card and OpenArray® file types. The solution is an interactive report that extends analysis beyond Ct or fold-changes to an accurate and dynamic view of the biological information most relevant to a gene-expression experiment, the companies explain.

    “Ingenuity iReport for real-time PCR is the perfect complement to our industry-leading PCR portfolio,” says Chris Linthwaite, head of genetic analysis, Life Technologies. “Our Real-Time PCR products produce data that is highly sensitive and specific with a broad dynamic range and at a cost-effective price per data point.

    “We have gone to great lengths to design a fully integrated marketing, e-commerce, and customer support experience to ensure that the combined real-time PCR iReport experience is as seamless and easy as the products themselves,” Linthwaite continues.

    In contrast to time-consuming manual searches for relevant publications and gene relationships, Ingenuity iReport for real-time PCR provides a more rapid and comprehensive understanding of pathways, processes, and diseases relevant to gene-expression results, the firms add. Peer-reviewed literature is cited throughout the report, allowing the underlying evidence to be easily accessed and referenced.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »